未對經營業績發生虧損事項進行業績預告 瑞康醫藥(002589.SZ)及相關人員吃警示函
格隆匯 8 月 21日丨瑞康醫藥(002589.SZ)公佈,公司於2020年8月21日收到中國證券監督管理委員會山東監管局《關於對瑞康醫藥集團股份有限公司及尹世強、俞斌採取出具警示函監管措施的決定》([2020]42號),現將主要內容公告如下:
“瑞康醫藥集團股份有限公司及尹世強、俞斌:2020年2月21日,你公司發佈了2019年度業績快報,稱2019年度歸屬於上市公司股東的淨利潤為-102,051.86萬元。之前,你公司未對經營業績發生虧損事項進行業績預告。
你公司的上述行為違反了《上市公司信息披露管理辦法》第二十五條的規定,尹世強、俞斌作為公司的總經理、財務總監,你們的行為違反了《上市公司信息披露管理辦法》第三條的規定。按照《上市公司信息披露管理辦法》第五十八條、第五十九條的規定,我局決定對你公司及尹世強、俞斌採取出具警示函的監管措施,並將相關情況記入證券市場誠信檔案。
如對本監督管理措施不服,可以在收到本決定書之日起60日內向中國證券監督管理委員會提出行政複議申請,也可以在收到本決定書之日起6個月內向有管轄權的人民法院提起訴訟。複議與訴訟期間,上述監督管理措施不停止執行。”
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.